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Edited by Miguel De la RosaAbstract Here we present the high-resolution NMR structure
of a chimera (SPCp41) between a-spectrin SH3 domain and
the decapeptide p41. The tertiary structure mimics perfectly
the interactions typically found in SH3–peptide complexes and
is remarkably similar to that of the complex between the sepa-
rate Spc-SH3 domain and ligand p41. Relaxation data conﬁrm
the tight binding between the ligand and SH3 part of the chi-
mera. This chimera will serve as a tool for a deeper understand-
ing of the relationship between structure and thermodynamics of
binding using a combination of NMR, stability and site-directed
mutagenesis studies, which can lead to an eﬀective strategy for
ligand design.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Proline-rich peptide1. Introduction
Adapter domains that recognize proline-rich sequences are
considered to be of key importance as they mediate transient
protein–protein interactions that are involved in signal trans-
duction. The Src-homology region-3 (SH3) domains are an
example of these classes of small protein modules. Their inter-
actions with polyproline peptides have been found to be highly
promiscuous and relatively weak, with binding aﬃnities rang-
ing between 5 lM and 100 lM [1,2]. Several residues of the
peptide are in a polyproline II (PPII) helical conformation
within the complex that is positioned on top the hydrophobic
surface of the SH3 domain deﬁned by the side chains of pre-
served aromatic residues, ﬂanked by the n-Src and RT loops,Abbreviations: SH3, Src-homology domain 3; Spc-SH3, SH3 domain
of chicken brain a-spectrin; R21A Spc-SH3, the R21A mutant of Spc-
SH3; p41, APSYSPPPPP decapeptide; SPCp41, single-chain chimeric
protein made by fusion between Spc-SH3 and p41; NMR, nuclear
magnetic resonance; NOESY, nuclear Overhauser enhancement spec-
troscopy; TOCSY, total correlation spectroscopy; RMSD, root mean
square deviation
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doi:10.1016/j.febslet.2007.01.032which play an important role in both the aﬃnity and the spec-
iﬁcity of binding [3–5].
SH3 domains are known to be involved in a variety of dis-
eases [3,4,6,7] and thus have become very important targets
for drug design [7,8]. The success in the design of high-aﬃnity
ligands for these small domains is, however, limited as the
structural-thermodynamic determinants of binding aﬃnity
and speciﬁcity in these interactions are not well understood.
One of the reasons for the relatively slow progress in under-
standing the determinants of SH3–peptide binding aﬃnity
and speciﬁcity is the diﬃculty in linking the structural informa-
tion with a quantitative accounting of the energetics of these
interactions [5,9–14]. This is due, in part, to the diﬃculty in
determining high-resolution structures of low-aﬃnity SH3-li-
gand complexes, which are often diﬃcult to crystallize for X-
ray diﬀraction and show few NOEs between the binding part-
ners in nuclear magnetic resonance (NMR) studies. Addition-
ally, most eﬀorts to elucidate the determinants of binding have
generally relied upon laborious titration studies, mainly by iso-
thermal titration calorimetry, involving the use of vast
amounts of protein and costly systematically-modiﬁed syn-
thetic peptides, which explains the relatively small amount of
this kind of studies in the literature. One of the possible ap-
proaches to circumvent these problems is to link covalently
the two binding partners so that the intramolecular SH3–pep-
tide complex is stabilised entropically.
With these aims we have previously designed a chimeric pro-
tein, named SPCp41, which includes the decapeptide APS-
YSPPPPP (p41) covalently attached to the a-spectrin SH3
domain (Spc-SH3) [15]. In this design we used a three-residue
linker to attach p41 to a circular permutant of Spc-SH3 (Spc-
S19P20s), which has its new C-terminus at the RT-loop, quite
close to the binding site for proline-rich peptides and adjacent
to the speciﬁcity pocket [16]. On the basis of the higher stabil-
ity observed for SPCp41 relative to Spc-S19P20s and the struc-
tural diﬀerences observed by CD and ﬂuorescence, we
proposed that the p41 sequence occupies the putative SH3
binding site in a similar fashion to that usually found in the
SH3–peptide complexes. The p41 ligand was initially designed
as a high-aﬃnity ligand for the Abl-SH3 domain [2] and binds
the Spc-SH3 domain and some of its mutants with moderate
aﬃnity (50–100 lM) [17,18].
Here we present the high resolution NMR structure of
SPCp41 and show that its three-dimensional structure contains
the interactions typically found in the complexes between SH3blished by Elsevier B.V. All rights reserved.
Table 1
Structural statistics for the 20 conformers of SPCp41a
Restraintsb
Short-range (ji–jj 6 1) 725
Medium range (2 6 ji–jj 6 4) 144
Long range (ji–jj P 5) 712
Torsion angle restraints
PHI 40
PSI 38
All 1659
Restraint statisticsc
Distance violations >0.0 A˚ 0
Torsion angle violations >0 0
Target function value (A˚2)
Average/best 0.066/0.046
Pairwise RMSDd of residues 7–77 in A˚
Backbone N, CA, C 0 0.34 ± 0.06
Heavy atoms 0.78 ± 0.09
Ramachandran plote
Most favoured regions (%) 73.5
Additional allowed regions (%) 24.4
Generously allowed regions (%) 0.5
Disallowed regions (%) 1.6
aThe statistics is obtained from an ensemble of twenty lowest-energy
structures for SPCp41 chimera.
bRestraint statistics reported for unique, unambiguous assigned NOEs.
cViolations are only reported when present in six or more structures.
dCoordinate precision is given as the average pair-wise Cartesian
coordinate root mean square deviations over the ensemble.
eValues obtained from the PROCHECK-NMR analysis [27] excluding
the ﬁrst seven highly ﬂexible residues.
Fig. 1. 800 MHz 1H–15N HSQC spectrum of the SPCp41 chimera recorded at
in the amino acid sequence. The two side chain NH2 protons of Asn and Gln
peaks of the two arginine residues are indicated by an arrow.
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interactions are closely similar to those in the complex between
the separate ligand p41 and the R21A mutant of Spc-SH3 [17].
This chimera will now facilitate extensive structure-based ther-
modynamic studies of the interactions at the SH3:peptide
interface by the use of site-directed mutagenesis in combina-
tion with stability measurements and high-resolution NMR.2. Materials and methods
2.1. Protein expression and puriﬁcation
The plasmid pETM-11 (Protein Expression and Puriﬁcation Core
Facility, EMBL Heidelberg, Germany) containing the chimera
SPCp41 gene covalently linked to a N-terminal 6·His tag and a
TEV protease cleavage site was expressed in Escherichia coli
BL21(DE3) strain (Novagen). Protein expression was induced
(OD600 = 0.6–0.8) with 1 mM IPTG at 37 C overnight. Cells were
resuspended in 50 mM phosphate, 0.3 M NaCl, pH 8.0 buﬀer (Column
Buﬀer: CB) and broken in a French press. The supernatant was loaded
on 5 mL of Ni-NTA resin (Qiagen) equilibrated with CB and washed
with CB, CB + 20 mM imidazole and CB + 50 mM imidazole. The
protein was eluted with CB + 500 mM imidazole and dialyzed in
TEV buﬀer (50 mM Tris–HCl pH 8.0, 0.5 mM EDTA) to eliminate
imidazole. The His-tag was cleaved by incubation at room temperature
overnight with TEV protease in presence of 1 mM ditiothreitol. The
cleaved SPCp41 was recovered by a second Ni-NTA chromatography
step. 15N- and 13C/15N-labelled proteins were puriﬁed from cells grown
in M9 minimal medium containing either 15NH4Cl (Tracer Tecnolo-
gias Analiticas S.L.) or 15NH4Cl and (
13C6)D-glucose (Spectra Stable
Isotopes) as the sole sources of nitrogen and carbon, respectively. Sam-
ple concentration was determined spectrophotometrically using an
extinction coeﬃcient of 16502 M1 cm1, determined using the Gill
and von Hippel method [19].30 C. Assignments are indicated by the corresponding residue number
residues are connected by a solid line in the ﬁgure. The 1He–15Ne cross-
A.M. Candel et al. / FEBS Letters 581 (2007) 687–692 6892.2. NMR spectroscopy
All NMR spectra were recorded on 1 mM SPCp41 samples in 93%
H2O/7% D2O or in D2O in 20 mM D5-glycine buﬀer pH 3.5 at
30 C on a Bruker US2 800 MHz spectrometer. Two-dimensional
homonuclear 1H total correlation spectroscopy (2D TOCSY, 60 ms
mixing time) [20] and nuclear Overhauser enhancement spectroscopy
(2D NOESY, 100 ms mixing time) [21] spectra were acquired on a
unlabelled sample in H2O and D2O. 2D heteronuclear single quantum
correlation (15N-HSQC), 15N-TOCSY–HSQC and 15N-NOESY–
HSQC [22] were acquired on a 15N-labelled sample. Triple resonance
spectra CBCA(CO)NH, CBCANH, HNCA, HN(CO)CA, HNCO
and HCCH–TOCSY were recorded on a 13C/15N-labelled sample [23].
NMR data were processed using XWINNMR/TOPSPIN (Bruker
Biospin, Karlsruhe, Germany) or NMRPipe [24], and analyzed by
SPARKY (T.D. Goddard and D.G. Kneller, University of California)
or NMRVIEW [25].
2.3. Spectral assignment
HNCA, HN(CO)CA, CBCANH, CBCA(CO)NH and HNCO
experiments were used for the backbone assignment and HCCH–
TOCSY and 15N-TOCSY–HSQC for the side-chain assignment. The
assigned resonances have been deposited in the BioMagResBank data-
base with accession code 15013.
2.4. Structure calculation
NOE cross peaks, obtained from the high-resolution 800 MHz 2D
NOESY spectra, were assigned using the automated NOE assignment
of CYANA [26]. Phi and psi torsion angle restraints were included
based on analysis of HN, 15N, 1Ha,
13Ca,
13CO and 13Cb chemical
shifts using the program PREDITOR [27]. The standard protocol
[26] was used with seven cycles of combined automated NOE assign-
ment and structure calculation of 100 conformers in each cycle, of
which the 20 structures with lowest target function value were selected
for further minimization and analysis. Input data and structure calcu-
lation statistics are summarized in Table 1. PROCHECK-NMR [28]
was used to analyze the quality of the structures and MOLMOL [29]
and PYMOL (http://www.pymol.org/) for visualization. The structural
coordinates and experimentally derived restraints have been deposited
in the Protein Data Bank with accession number 2JMC.
Solvent-accessible surface areas (ASA) were calculated using the
program NACCESS [30] using the default parameters for the water
probe radius (1.4 A˚), z-slice (0.05 A˚) and van der Waals radii. The bur-
ied surface area within the chimera was calculated by assuming resi-
dues 1–67 as the SH3 domain and residues 68–77 as the p41 part of
the chimeric protein.
2.5. Heteronuclear NOE experiments
1H–15N steady-state NOEs of SPCp41 were obtained from two series
of 2D experiments with coherence selection achieved by pulse ﬁeld gra-
dients [31] at 30 C at 800 MHz and on a Varian NMR SystemsFig. 2. Stereo view of the ensemble of 20 lowest-energy NMR
structures of the SPCp41 chimera superimposed on the backbone
atoms (N, Ca, C 0) of residues 7–77.600 MHz spectrometer at 25 C. The 1H–15N heteronuclear NOEs
were determined from the ratio of peak intensities with and without
the saturation of the amide protons for 3 s.3. Results and discussion
3.1. The structure of the chimera SPCp41
1H, 15N and 13C assignments were obtained by the use of the
combination of selected triple-resonance spectra. Fig. 1 shows
a 1N–15N HSQC spectrum of SPCp41 with the 1H and 15N
assignment indicated. Fig. 2 shows a stereo representation of
the superposition of the ensemble of 20 SPCp41 structures de-
rived from the automatic NOE assignment protocol in CYA-
NA (see Section 2). The ensemble fulﬁls very well the
experimental data (Table 1). Moreover, the structures satisfyFig. 3. Comparison of the backbone dynamics and backbone RMSD
calculated over the ensemble of 20 structures presented in Fig. 2. (A)
Bar diagram of the backbone positional RMSD calculated using
MOLMOL. (B) The heteronuclear 1H–15N NOEs (H–N NOE)
measured at 600 and 800 MHz are presented. Errors are estimated to
be in the order of 2%. The diﬀerent structural elements are shown in
the centre of the two panels with b-strands numbered as in WT a-
spectrin SH3.
AB
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using CYANA [32]. The success of the approach can be attrib-
uted to the use of a single high-quality 800 MHz 2D NOESY
spectrum and the complete set of assignments of almost all
proton frequencies (>95%) used for the automatic NOE
assignment stage and the addition of torsion angle restraints
derived form the combination of selected 1H, 15N and 13C
chemical shifts. The 1H–15N NOE data reveal a good correla-
tion with the backbone root mean square deviations (RMSD)
of the calculated ensemble (Fig. 3). The structural disorder ob-
served for the N-terminus, loop 48–52 and the linker region
(residues 65–67) connecting the SH3 domain to the p41 ligand
(residues 68–77) can be ascribed to the higher ﬂexibility in
these regions of the protein as indicated by the smaller hetero-
nuclear NOE values. Moreover, the NOE values following the
linker region, which corresponds to the ﬁrst ﬁve residues of the
p41 part, increase and are closely similar to those of the more
rigid regions of the protein, conﬁrming the tight intramolecu-
lar binding between the ligand and SH3 domain part in the chi-
mera.
Fig. 4 shows a superposition of the structure of SPCp41 on
that of the circular permutant Spc-S19P20s (pdb code: 1TUC
[16]) that was used as template for the chimeric protein. The
SH3 part of the structure is very similar to the Spc-S19P20s
structure with a backbone pair wise RMSD of 0.87 A˚. The
structure is also closely similar to that of the R21A mutant
of Spc-SH3 (pdb code: 2JMA) that was recently determined
by NMR [17] with a backbone pair wise RMSD of 0.83 A˚.
Moreover, the unfavorable torsion angles for residue 47 found
in the WT X-ray structure of Spc-SH3 [33] and in the NMR
structure of R21A Spc-SH3 [17] as well as for the correspond-
ing residue in Spc-S19P20s [16] is also present in all structures
of the SPCp41 NMR ensemble (residue Asn32). The positive /
angle sign for Asn32 was experimentally conﬁrmed by the
analysis of a 15N-HSQC derived spectrum [34].
3.2. Comparison between the SPCp41 chimera and the R21A
Spc-SH3:P41 and complex
Fig. 5 shows the binding interface of SPCp41 and that of the
R21A Spc-SH3:pP41 complex [17]. The p41 ligand adopts aFig. 4. Stereoview of the lowest-energy SPCp41 structure (blue)
superimposed on the WT X-ray structure of the permutant Spc-
S19P20s (1TUC, green) and a representative NMR structure of the
R21A Spc-SH3:p41 complex (2JMA, only the SH3 domain is shown in
red) for comparison. Superposition was done on the backbone N, Ca,
C 0 atoms of 8–46 and 53–62 of SPCp41 on the corresponding residues
23–61 and 7–16 in Spc-S19P20s and in R21A Spc-SH3, respectively.very similar conformation in both structures (Fig. 5A). Small
structural diﬀerences are mainly around Tyr4, likely due to
adapting to the slightly diﬀerent conformation of the chain
at the RT loop (Lys18 in R21A Spc-SH3 forms a H-bond with
Tyr4 of p41). The aromatic residues and Pro39 in SPCp41
(Pro54 in R21A Spc-SH3), highly preserved among SH3 do-
mains and critical for binding polyproline motifs, are posi-
tioned in the same way in both structures (Fig. 5B). We used
LIGPLOT [35] to analyze hydrophobic contacts and hydrogen
bonds within the chimera and the R21A Spc-SH3:P41 com-
plex; the results are summarized in Table 2. Generally the same
contacts are found in the two protein–ligand complexes,
although a few diﬀerences are observed. The absence or pres-
ence of certain contacts are due to the structural diﬀerences
around Tyr4 of p41 in relation to the original RT loop in
R21A Spc-SH3, partly due to the absence of the H-bond part-
ner in SPCp41 (Lys18 in R21A Spc-SH3). If we assume the p4113
15
41
18
52
57
54
59
61
26
37
42
39
Fig. 5. The SPCp41 and R21A Spc-SH3:p41 binding interface. (A)
Stick representation of SPCp41 (p41 blue, SH3 cyan mesh) and p41 in
complex with R21A Spc-SH3 (p41 yellow, SH3 red mesh). Structural
diﬀerences are mainly around Tyr4 likely due to the absence of the H-
bond partner in SPCp41 (Lys18 in R21A Spc-SH3). (B) Residues of
SH3 involved in binding (SPCp41 red, R21A Spc-SH3 cyan, p41 blue).
Residue 18 in R21A Spc-SH3 is colored in green.
Table 2
Intermolecular contactsa statistics calculated over the ensemble of 20 chimera structures
Interacting residues Hydrogen bonds Non-bonded contacts Occurrence total (%) Interacting residue in R21A Spc-SH3
p41 Chimera M–M S–S M–S
Ala1 Phe37 0 0 0 1 35 Phe52 (3, 95%)
Pro2 Trp26 0 0 0 5 100 Trp41 (7, 100%)
Pro2 Phe37 0 0 0 4 100 Phe52 (2, 50%)
Tyr4 Trp26 0 0 0 3 100 Trp41 (1, 95%)
Tyr4 Trp26 0 0 1 0 100 Trp41 (0, 100%)
Pro6 Pro39 0 0 0 1 100 Pro54 (1, 70%)
Pro6 Asp25 0 0 0 2 25 Asp40 (2, 100%)
Pro6 Trp26 0 0 0 2 100 Trp41 (3, 100%)
Pro7 Tyr61 0 0 0 1 95 Tyr15 (1, 80%)
Pro9 Tyr59 0 0 0 3 100 Tyr13 (2, 100%)
Pro9 Tyr42 0 0 0 2 100 Tyr57 (3, 100%)
Pro10 Tyr59 0 0 0 8 100 Tyr13 (2, 65%)
Pro2 Asn23 0 0 0 1 90 –
Ser5 Trp26 0 0 0 1 85 –
Pro7 Trp26 0 0 0 2 100 –
Pro7 Pro39 0 0 0 3 100 –
Tyr4 – 0 1 0 – – Lys18 (0, 100%)
Pro7 0 0 1 – – Tyr57 (0, 95%)
aIntermolecular contacts were analyzed with LIGPLOT [35] using the default settings. Contacts are reported if present in at least 10 of the 20
structures or in at least 1 of the 20 structures when the corresponding contact in R21A Spc-SH3:P41 is present in 10 or more of the 20 models in pdb
entry 2JMA [16]. Hydrogen bonds are reported for main-chain to main-chain (M–M), side-chain to side-chain (S–S) and main-chain to side-chain
(M–S). The average number of non-bonded contacts is reported, as well as the percentage of occurrences of a contact. The corresponding interacting
residue in R21A Spc-SH3 for a certain contact and the number of contacts and occurrence in the 20 structures (between brackets, respectively) are
given in the last column. The last two rows correspond to contacts present in R21A Spc-SH3:P41 that are not present in any of the 20 structures
reported here. For comparison, residue numbering of 1–10 is used of the p41 part of the chimera (corresponding to residues 68–77 in SPCp41).
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the SH3 part of the chimera (residues 1–67), the interaction
buries 648 ± 8 A˚2 of non-polar area and 227 ± 28 A˚2 of polar
area, slightly less than in the R21A Spc-SH3:P41 complex
(686 ± 11 A˚2 and 241 ± 11 A˚2, respectively [17]), in good agree-
ment with the structural details of both complexes. These small
diﬀerences can at least partly be ascribed to the simple model
used to calculate the accessible area for the chimera.
3.3. Contribution of cross-linking the protein and ligand on the
binding entropy
In a previous article we reported the diﬀerences in thermody-
namic magnitudes of unfolding of Spc-S19P20s and SPCp41
[15] in comparison with the Gibbs energy of binding of p41
to Spc-S19P20s. It was concluded that the crosslink has a con-
siderable contribution to the conﬁgurational entropy of bind-
ing (TDS about 11 kJ/mol) that is crucial to stabilize of
the interactions at the binding interface. In a recent paper
[36], Zhou has analyzed quantitatively the stabilizing eﬀect of
cross-linking between SH3 domains and proline-rich peptides
using ﬂexible linker segments. This analysis predicts for
SPCp41 a net stabilization of 14.9 kJ/mol relative to Spc-
S19P20s, consistent with our experimental results.
The stabilization produced by the crosslink is interpreted in
terms of the entropic beneﬁt of increasing the eﬀective concen-
tration of p41 up to about 65 mM. Accordingly, although the
isolated p41 ligand and the Spc-S19P20s domain have a low
intrinsic aﬃnity (Kd = 160 lM), it is largely compensated by
the entropy gain of tethering, so that the chimera behaves very
much as a two-state unfolding protein. The results presented in
this work conﬁrm the tight intra-molecular binding between
the p41 sequence segment and the SH3 binding site, with a
well-deﬁned conformation and relatively high heteronuclear
NOE values for the residues at the binding interface.4. Concluding remarks
The success in the design of high-aﬃnity ligands for SH3 do-
mains is up-to-date limited as we do not know how changing a
particular interaction at the binding interface modiﬁes the
binding Gibbs energy. The work described here shows that
we fully succeeded in obtaining a single-chain globular, chime-
ric protein that mimics the interactions found in the complex
between the a-spectrin SH3 domain and the polyproline ligand
p41. We have now a tool in hand enabling a straightforward
approach to increase our understanding on how structure is
linked to the thermodynamics of binding by the use of a com-
bination of NMR, stability measurements and site-directed
mutagenesis. Such an increased understanding will facilitate
an eﬀective strategy of rational design of ligands.
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